Language selection

Search

Details for: NEXAVAR

Company: BAYER INC

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02284227NEXAVARSORAFENIB (SORAFENIB TOSYLATE)200 MGTABLETORAL
Search Reported Side Effects Report a Side Effect

Summary Reports

Summary Basis of Decision
Summary Safety Review - NEXAVAR (sorafenib) - Thyroid Gland Dysfunction
Summary Safety Review - Vascular Endothelial Growth Factor Receptor Inhibitors - Thrombotic Microangiopathy

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: